These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10166155)

  • 41. What you should know about device recalls.
    OR Manager; 2002 Apr; 18(4):21. PubMed ID: 11962164
    [No Abstract]   [Full Text] [Related]  

  • 42. Medical device and laboratory product problem reporting from physicians' offices.
    Reynolds CT; Dierksheide WC
    J Fam Pract; 1991 Jun; 32(6):634-6. PubMed ID: 2040891
    [No Abstract]   [Full Text] [Related]  

  • 43. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

  • 44. Device tracking: what's covered? How'll it work?
    Muehlbauer EJ
    Health Facil Manage; 1992 Oct; 5(10):40, 42-3. PubMed ID: 10121451
    [No Abstract]   [Full Text] [Related]  

  • 45. Users to report device-related deaths to FDA.
    OR Manager; 1991 Jan; 7(1):1, 13. PubMed ID: 10110321
    [No Abstract]   [Full Text] [Related]  

  • 46. Medical devices post-approval studies program: vision, strategies, challenges and opportunities.
    Marinac-Dabic D; Bonhomme M; Loyo-Berrios N; Gross T; Ciperson R; Gardner S; Marcarelli M
    Food Drug Law J; 2007; 62(3):597-604. PubMed ID: 17915402
    [No Abstract]   [Full Text] [Related]  

  • 47. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
    Shea LL; Hanson A; Guglielmetti TM; Levy K
    Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388
    [No Abstract]   [Full Text] [Related]  

  • 48. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postmarketing surveillance of medical devices--filling in the gaps.
    Resnic FS; Normand SL
    N Engl J Med; 2012 Mar; 366(10):875-7. PubMed ID: 22332950
    [No Abstract]   [Full Text] [Related]  

  • 50. Risk assessment and management as related to evaluation of medical devices: a view from the FDA.
    Callahan TJ; Marlowe DE
    J Long Term Eff Med Implants; 1993; 3(4):269-76. PubMed ID: 10172029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surveillance of medical technologies.
    Thacker SB; Berkelman RL
    J Public Health Policy; 1986; 7(3):363-77. PubMed ID: 3771786
    [No Abstract]   [Full Text] [Related]  

  • 52. Blowing the whistle on faulty medical products.
    Harris HR
    Surg Technol; 1993 Aug; 25(8):13, 18. PubMed ID: 10127818
    [No Abstract]   [Full Text] [Related]  

  • 53. Medical Device Manufacturing and Medical Device Reports (MDR).
    Arellano V
    Insight; 2009; 34(3):24-5. PubMed ID: 19708431
    [No Abstract]   [Full Text] [Related]  

  • 54. Safe Medical Devices Act: reporting rules face hurdle.
    Shepherd M; Furst E
    Health Facil Manage; 1996 Apr; 9(4):38. PubMed ID: 10156096
    [No Abstract]   [Full Text] [Related]  

  • 55. When a drug is withdrawn.
    Johnson LJ
    Med Econ; 2005 May; 82(10):68. PubMed ID: 15977763
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medical device preemption after Medtronic, Inc. v. Lohr.
    Neraas MB
    Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731
    [No Abstract]   [Full Text] [Related]  

  • 59. Home health care nursing: liability and risk management for "informed consent" and "The Safe Medical Devices Act" duties.
    Blumenthal JB; Hayes EJ
    J Health Hosp Law; 1995; 28(5):286-91, 309. PubMed ID: 10156294
    [No Abstract]   [Full Text] [Related]  

  • 60. The FDA and the tort system: postmarketing surveillance, compensation, and the role of litigation.
    Struve CT
    Yale J Health Policy Law Ethics; 2005; 5(2):587-669. PubMed ID: 16052895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.